TCL Archive ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication February 17, 2012
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive Entire Construction Budget In 1983 Goes to Two Grants; Help May Be On The Way February 25, 1983
TCL Archive Senate Subcommittee Okays $1 billion For NCI In FY 1980, Agrees To Block Obey Reprogramming June 15, 1979
